Baystate Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$12.4K Hold
250
﹤0.01% 679
2023
Q3
$13.4K Buy
250
+130
+108% +$6.93K ﹤0.01% 528
2023
Q2
$6.47K Buy
+120
New +$6.46K ﹤0.01% 652
2022
Q1
Sell
-8
Closed 933
2021
Q4
$0 Sell
8
-136
-94% -$6.73K ﹤0.01% 961
2021
Q3
$7K Buy
144
+136
+1,700% +$6.92K ﹤0.01% 569
2021
Q2
$0 Hold
8
﹤0.01% 852
2021
Q1
$0 Sell
8
-108
-93% -$5.19K ﹤0.01% 820
2020
Q4
$6K Hold
116
﹤0.01% 482
2020
Q3
$6K Hold
116
﹤0.01% 454
2020
Q2
$6K Sell
116
-284
-71% -$13.8K ﹤0.01% 446
2020
Q1
$17K Hold
400
﹤0.01% 311
2019
Q4
$20K Buy
+400
New +$18.7K ﹤0.01% 322
2018
Q2
Sell
-1,127
Closed -$45K 700
2018
Q1
$45K Hold
1,127
0.01% 197
2017
Q4
$49K Hold
1,127
0.01% 203
2017
Q3
$57K Buy
+1,127
New +$54.5K 0.01% 171

Other funds holding SNY

Baystate Wealth Management's SNY Position: Q4 2023 in Review

Baystate Wealth Management held its Sanofi (SNY) position steady in Q4 2023 at 250 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #679.

Baystate Wealth Management first reported a position in SNY in Q3 2017 and has held it in 15 quarters since. The position peaked at $57K in Q3 2017. 707 funds tracked by Wall St. Rank hold SNY as of Q4 2023.

  • Baystate Wealth Management held 250 shares of Sanofi worth $12.4K as of Q4 2023.
  • Baystate Wealth Management left its Sanofi share count unchanged in Q4 2023.
  • Sanofi made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #679 holding.
  • Baystate Wealth Management first reported a position in Sanofi in Q3 2017 and has held it in 15 quarters since.
  • Baystate Wealth Management's Sanofi position peaked at $57K in Q3 2017.
  • 707 funds tracked by Wall St. Rank held Sanofi as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.